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Voltage-gated Na+ (NaV) channels initiate neuronal
action potentials. NaV channels are composed of
a transmembrane domain responsible for voltage-
dependent Na+ conduction and a cytosolic
C-terminal domain (CTD) that regulates channel
function through interactions with many auxiliary
proteins, including fibroblast growth factor homolo-
gous factors (FHFs) and calmodulin (CaM). Most
ion channel structural studies have focused on
mechanisms of permeation and voltage-dependent
gating but less is known about how intracellular
domains modulate channel function. Here we report
the crystal structure of the ternary complex of
a human NaV CTD, an FHF, and Ca
2+-free CaM at
2.2 A˚. Combined with functional experiments based
on structural insights, we present a platform for
understanding the roles of these auxiliary proteins
in NaV channel regulation and the molecular basis
of mutations that lead to neuronal and cardiac
diseases. Furthermore, we identify a critical interac-
tion that contributes to the specificity of individual
NaV CTD isoforms for distinctive FHFs.
INTRODUCTION
In the axon initial segment of neurons a large and rapid influx of
sodium ions (INa) through voltage-gated Na
+ (NaV) channels is
responsible for the rapid upstroke of the action potential. Dysre-
gulation of NaV channels leads to a variety of neurological disor-
ders. Mutations in SCN1A and SCN2A, which encode NaV1.1
and NaV1.2, respectively, lead to various epilepsy syndromes.
Both gain- and loss of-function mutations have been described
(Meisler et al., 2010), emphasizing the importance of the precise
regulation of channel function. Mutations in the SCN5A-encoded
cardiac NaV1.5, with similar biophysical consequences, have
been linked to various inherited arrhythmias (Zimmer and Surber,
2008).Structure 20, 1NaV channels, which are monomers with tetrameric repeats of
six transmembrane (TM) segments, share a similar architecture
with other voltage-gated cation (Ca2+ and K+) channels. In these
six TM segments, the first four TM segments (S1–S4) comprise
the voltage-sensor domain (VSD) and the last two TM segments
(S5 and S6) make up a central pore when assembled as
a tetrameric configuration. The pore mediates selective cation
permeation through its selectivity filter, and this conduction
can be allowed (open) or obstructed (closed) by a ‘‘gate’’ near
the intracellular membrane surface of the pore lined by S6. In
voltage-gated cation channels, VSDs control pore gating upon
sensing a change in membrane voltage. Four VSDs are located
on the periphery of the central pore (Figure S1 available online).
Although the pore-forming a-subunit is responsible for the
fundamental properties of voltage-dependent Na+ conduction,
auxiliary proteins regulate channel function. Most voltage-gated
ion channel structural studies have focused on the general
mechanisms of permeation and voltage-dependent gating by
studying prototypical Kv channels, such as an archaeal Kv
channel (KvAP), the Shaker-type Kv channel (Kv1.2), and the
NaV channel from Arcobacter butzleri (NavAb) (Jiang et al.,
2003; Lee et al., 2005; Long et al., 2005; Payandeh et al.,
2011). Much less is known about how their intracellular domains,
such as the NaV cytoplasmic C-terminal domain (CTD), modulate
channel function, however. Most NaV channel auxiliary proteins
interact with the cytoplasmic C-terminal domain (CTD) of the
channel’s a-subunit (Figure S1). Among these are the NaV
b subunit, through its short cytoplasmic domain (Spampanato
et al., 2004), calmodulin (Mori et al., 2003), and members of
the fibroblast growth factor homologous factor (FHF) family
(Liu et al., 2001). Not only is the NaV CTD important for the regu-
lation of channel activity, but a significant number of disease-
causing mutations are localized to NaV CTDs (Lossin, 2009;
Ohmori et al., 2006; Spampanato et al., 2004) and their associ-
ated proteins (van Swieten et al., 2003).
FHFs belong to the fibroblast growth factor (FGF) superfamily
(Smallwood et al., 1996), but are functionally different from
canonical FGFs (Olsen et al., 2003). The four FHF genes
(FGF11–FGF14) encode ten isoforms generated by alternative
splicing of exons that encode an extended N terminus preceding
a coredomain that is homologouswith FGFs.Unlike FGFs, FHFN
termini lack signal sequences and so are not secreted from cells167–1176, July 3, 2012 ª2012 Elsevier Ltd All rights reserved 1167
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Structure of a NaV CTD in complex with FHF and CaM(Smallwood et al., 1996). Moreover, they cannot activate FGF
receptors because of subtle structural differences in their FGF-
like core (Olsen et al., 2003). Rather than serving as extracellular
growth factors, FHFs remain intracellular, bind to NaV CTDs, and
modulate NaV channel function (Liu et al., 2001, 2005). This NaV-
modulating role was highlighted by the identification of FGF14 as
the locus for spinocerebellar ataxia 27 (van Swieten et al., 2003),
and demonstration that the mutant FGF14 reduces NaV channel
currents, alters channel gating, and decreases neuronal excit-
ability in a dominant negative manner (Laezza et al., 2007).
Although several FHFs are expressed in the brain, they are not
functionally redundant. Gene deletion of Fgf14 in mice causes
ataxia, dyskinesia, and dystonia (Wang et al., 2002). Knockout
of Fgf12 exacerbates all of those phenotypes and exaggerates
the effects on neuronal NaV channels (Goldfarb et al., 2007). In
addition to regulating Na+ conduction, FHFs also affect NaV
channel trafficking to the plasma membrane and targeting to
the axon initial segment (Laezza et al., 2007; Wang et al., 2011b).
The ubiquitous Ca2+ sensor calmodulin (CaM) also binds NaV
CTDs, near the putative FHF interaction site. A familial autism-
associated mutation localizes to the CaM binding region in
NaV1.2 and is postulated to alter regulation of Ca
2+-dependent
NaV1.2 channel function (Weiss et al., 2003). How CaM
controls NaV channel function is not clear, and whether Ca
2+
also affects NaV channel function through direct binding to
a putative EF hand in the CTD has been controversial (Miloushev
et al., 2009; Shah et al., 2006).
The structural basis by which FHFs or CaM regulate NaV
channels is not known as current structural information about
NaV CTDs and these binding partners is limited to studies of
any one component in isolation (Chagot et al., 2009; Goetz
et al., 2009; Miloushev et al., 2009; Olsen et al., 2003; Schu-
macher et al., 2004), or one binding partner and its minimal
CTD binding target in the case of CaM and the CaM-binding IQ
motif peptide in NaV CTDs (Chagot and Chazin, 2011; Feldkamp
et al., 2011). These structures provide little context for how
these partners participate in NaV channel regulation and how
mutations in NaV CTDs affect channel function. Moreover, indi-
vidual FHFs impose distinctive modulation on specific NaV
channel isoforms (Lou et al., 2005; Wang et al., 2011b), yet how
this specificity is encoded is not known. Sequence analysis of
the putative FHF and NaV CTD interaction sites (Goetz et al.,
2009; Liu et al., 2003) shows that these sites are highly conserved
among the NaV CTDs and FHFs, respectively, suggesting that
specificity is encoded by unidentified features within these
conserved domains. We therefore aimed to solve the structure
of the ternary complex of aNaVCTD, an FHF, andCaM to provide
a foundation for understanding these interactions and the conse-
quent regulation of NaV function in neurons and the heart.
RESULTS
The Structure of the Ternary Complex of Nav1.5 CTD,
FGF13, and Ca2+-free CaM
We coexpressed a NaV1.5 CTD (the predicted structured region
of NaV1.5 from the end of IVS6 at amino acid 1773 to amino acid
1940), an FHF (FGF13U, which has a short N-terminal extension),
and CaM in Escherichia coli and purified the ternary complex by
Co2+ affinity chromatography followed by size exclusion chro-1168 Structure 20, 1167–1176, July 3, 2012 ª2012 Elsevier Ltd All rigmatography. We chose this NaV CTD and FHF because the re-
sulting ternary complex was biochemically the most stable and
yielded well-diffracting crystals among the several different
combinations of NaV CTDs and FHFs tested. The sequence of
the NaV CTD is highly conserved among the subtypes (over
75% identical among NaV1.5, NaV1.1, and NaV1.2), and the solu-
tion structures of the EF-hand fragments of the NaV1.2 CTD and
NaV1.5 CTD are nearly identical (Chagot et al., 2009; Miloushev
et al., 2009). We postulated that failed previous attempts to crys-
tallize a NaV CTD in complex with an FHF (Goetz et al., 2009)
might be due to the lack of inclusion of CaM and consequent
nonspecific interactions among complexes containing a NaV
CTD and FHF because we observed by size-exclusion chroma-
tography an apparent higher order (stoichiometry > 1:1, NaV1.5
CTD:FGF13) binary complex that was reduced by addition of
CaM (data not shown). The ternary complex was stable. Its
elution volume on the size exclusion column was consistent
with a molecular weight about equal to the sum of its individual
components (60 kDa), indicating the stoichiometry of the
ternary complex is 1:1:1 (Figure S2). The resultant ternary
complex was crystallized in the space group P213 (a = b = c =
126.04 A˚) with one copy of the ternary complex in each asym-
metric unit. The crystals were grown in the presence of 5 mM
EGTA and diffracted to 2.2 A˚ Bragg spacings. The experimental
phases were derived by single anomalous dispersion from sele-
nomethionine-substituted crystals. The final model contains the
NaV CTD amino acids 1776–1928; FGF13U amino acids 11–158
(because the N-terminal ‘‘U’’ extension that defines this isoform
is not present in the model, it is hereafter designated ‘‘FGF13’’);
and the entire CaM except for the N-terminal four amino acids
and the loops from residues 22–27 and 57–61 in the N-lobe.
The model refined to a free R factor of 22.7% (Table 1).
Figure 1 shows the overall architecture of the ternary complex.
The NaV CTD is comprised of one globular domain (a1–a5) fol-
lowed by an extended 29-amino acid helix (a6) that contains
the CaM-binding IQ motif in its proximal portion. FGF13 binds
to the globular domain of the CTD. The five a helices in the glob-
ular domain of the NaV CTD are separated by four short anti-
parallel b strands. The first four helices (a1–a4) with two b strands
(b1 and b3) adopt a paired EF-hand fold, as was observed in
NMR structures of NaV CTD fragments containing only a1–a4
(root-mean-square deviation [rmsd] of 0.62 A˚; Figure S3) (Chagot
et al., 2009; Miloushev et al., 2009). Addition of a5 plus a loop
between a5 and a6 and a short b strand (b4) to the paired EF-
hand fold creates the binding site for FGF13 (Figure 1C). The
presence of b4 turns the loop between a3 and b3 into a short
b strand (b2) that forms a short b sheet with the rest of the
b strands (b1–b4) (Figure 1C).
Although our Nav CTD construct starts right after S6 on the
basis of the structure of the prokaryotic Nav channel NavAb,
we are not able to orient our ternary complex relative to the
NavAb structure unambiguously given the lack of experimental
constraints. Two hypothetical orientations of the ternary
complex relative to the NavAb structure embedded in the
membrane are shown in Figure S4.
Specific Interactions between the Nav CTD and FHF
Initial analysis of the interaction surface between the NaV CTD
and FGF13 provides a means to understand functionalhts reserved
Figure 1. Overall Architecture of the Ternary Complex of the NaV
CTD, FGF13, and CaM
(A) Structure of the NaV1.5 CTD (green) in complex with FGF13 (yellow) and
CaM (magenta).
(B) Same as (A) but rotated 180.
(C) Zoomed-in view of the NaV CTD with the same orientation as (B).
Secondary structural elements are labeled accordingly. See also Figures S1,
S2, S3, and S4.
Table 1. Data Collection, Phasing, and Refinement Statistics
Native SeMet Derivative
Data Collection
Space group P213 P213
Cell dimensions
a, b, c (A˚) 126.04, 126.04,
126.04
125.57, 125.57,
125.57
a, b, g () 90, 90, 90 90, 90, 90
Peak
Wavelength (A˚) 1 0.97936
Resolution (A˚) 50–2.2 (2.24–2.2)a 50–2.91 (2.96–2.91)
Rsym or Rmerge (%) 6.7 (36.0) 10.4 (51.4)
I/sI 36.9 (2.1) 47.88 (5.0)
Completeness (%) 99.8 (87.4) 100 (100)
Redundancy 8.2 (3.0) 17.6 (13.8)
Refinement
Resolution (A˚) 2.2
No. reflections 34,027
Rwork/ Rfree (%) 21.0/22.7
No. Atoms
Protein 3,488
Mg2+ 3
Water 202
B-factors (A˚2)
Protein 51.58
Mg2+ 44.03
Water 51.33
Rmsd
Bond lengths (A˚) 0.011
Bond angles () 0.823
aHighest resolution shell is shown in parenthesis. Rmds, root-mean-
square deviation.
Structure
Structure of a NaV CTD in complex with FHF and CaMconsequences of disease-causing mutations in NaV CTDs, but
yields little initial insight into the specificity of CTD-FHF pairwise
interactions and functional consequences. The shape of the NaV
CTD binding surface on FGF13 is complementary to that of the
FGF13-binding surface on the CTD as indicated by a relatively
high shape complementary index of 0.67 (Lawrence and
Colman, 1993). The buried surface area is 2,350 A˚. The
FGF13-binding surface on the NaV CTD is dominated by a
depression formed by a4 and the sequential segments starting
with the carboxy-terminal segment of a5, the subsequent
extended loop, b4, and the beginning of a6 (amino acids
Phe1879 to Arg1898) (Figures 1C and 2B). Consistent with our
recent biochemical and functional studies (Wang et al., 2011a),
residues distal to Ser1885 contribute significantly to the FHF
interaction site on NaV1.5. The NaV CTD binding surface on
FGF13, highly conserved among the other FHF family members,
contains several knob-like structures that fit into the NaV CTD
depression (Figure 2). The main anchor appears to be a knob
formed by the side chains of Leu56 and Arg57 on FGF13 that
protrudes into the NaV CTD to interact with His1849 and
Asp1852 of a4 (Figure 2C). A second protrusion on FGF13Structure 20, 1(Asn97) fits into a crevice on the NaV CTD formed between
Asp1839 and Pro1841. The involvement of these interacting
residues is underscored by disease-associated mutations. For
example, epilepsy-associated mutations in NaV1.1, D1866Y
(Spampanato et al., 2004) and T1909I (Ohmori et al., 2006),
reside in residues (Asp1852 and Thr1895 in the NaV1.5 CTD,
respectively) that form contacts with FGF13 (Figures 2 and S5).
Additionally, D1839G in NaV1.5, which accepts the knob formed
by Asn97 on FGF13, has been associated with the fatal cardiac
arrhythmia long QT syndrome (Benhorin et al., 1998). Because
the key residues that form the FGF13 binding surface are
conserved among the other NaV CTDs and the critical residues
forming the complementary NaV CTD binding surface on
FGF13 are conserved among the other FHFs, this interaction
motif is likely conserved among other NaV CTD-FHF pairs.
How, then, is specificity encoded between specific NaVs and
FHFs? The variable FHF N-termini may contribute, but cannot
explain why FGF12B (that essentially lacks the extended N
terminus found in all other FHF isoforms) can bind to and modu-
late NaV1.5, but not NaV1.1, as we showed (Wang et al., 2011b).
Comparison of the determinants for FGF13 binding in NaV1.5167–1176, July 3, 2012 ª2012 Elsevier Ltd All rights reserved 1169
Figure 2. Interactions between NaV CTD and FGF13
(A) Surface representation of the ternary complex of the NaV CTD (green),
FGF13 (yellow), and CaM (magenta). The interaction surfaces between the
NaV1.5 CTD and FGF13 (within 4 A˚ each other) are colored gray. An electro-
static interaction that may be important is shown in red (see below).
(B and C) The FGF13-interacting surface on the NaV1.5 CTD and the NaV1.5
CTD-interacting surface on FGF13, respectively. In each case, the highlighted
molecule is rotated 90 from (A). Two electrostatic interacting pairs thatmay be
important are shown in red (E1890 in NaV1.5 CTD and K14 in FGF13) and blue
(R1898 in NaV1.5 CTD and Y98 in FGF13), respectively.
(D and E) The electrostatic potential surface representations of (B) and (C),
respectively. The potential was calculated from 5 kT (negatively charged
amino acids) to 5 kT (positively charged amino acids) using the program
Adaptive Poisson-Boltzmann Solver (APBS) (Baker et al., 2001).
See also Figures S3, S4, and S5.
Structure
Structure of a NaV CTD in complex with FHF and CaMwith the homologous amino acids in the NaV1.1 CTD identified
one difference: Glu1890, which interacts with Lys14 of FGF13
by a salt bridge (Figures 2C, highlighted in red, and 3A), is re-
placed by a glutamine (Gln1904) at the homologous position in
NaV1.1. We speculated that loss of the salt bridge with Lys9
(homologous to Lys14 in FGF13) contributes to the reduced
affinity observed between FGF12B and NaV1.1 (Wang et al.,
2011b); as FGF12B has the shortest N-terminal extension
among the FHF family members, this loss of binding energy
might be particularly costly. To test this hypothesis we per-
formed a charge reversal swap between Lys9 in FGF12B and
Glu1890 in NaV1.5 and analyzed the effects on binding affinity
between the NaV1.5 CTD and FGF12B using isothermal titration
calorimetry. Mutating either Lys9 in FGF12B to Glu (FGF12BK9E)1170 Structure 20, 1167–1176, July 3, 2012 ª2012 Elsevier Ltd All rigor Glu1890 in NaV1.5 to Lys (Nav1.5 CTD
E1890K) reduced binding
affinity by at least 20-fold (Figure 3C and Table 2). However, the
affinity between bothmutants was restored to the level seen with
the wild-type pair. Because we have equilibrium binding data for
the wild-type and charge-reversed mutants of Nav1.5 and
FGF13, we performed a thermodynamic double mutant cycle
analysis to measure the degree of energetic coupling between
these sites. The resulting energetic coupling constant for the
salt bridge interaction is 1100 (4 kcal/mol). This high value
(>5 is considered significant) suggests that the salt bridge inter-
action is energetically significant and formed by charged-
hydrogen bonding (Hidalgo and MacKinnon, 1995). Consistent
with these results, FGF12BK9E copurifiedwith Nav1.5 CTDE1890K,
like the wild-type pair, when coexpressed in E. coli. Neither
FGF12BK9E nor Nav1.5 CTDE1890K copurified with the wild-type
binding partner (Figure 3D). The consequences upon channel
function were consistent with the binding data. As previously
shown, FGF12B induced a depolarizing shift in the V1/2 of
steady-state inactivation of NaV1.5 currents (Wang et al.,
2011b). In contrast, the FGF12BK9E mutant did not modulate
steady-state inactivation, nor was steady-state inactivation of
Nav1.5E1890K modulated by wild-type FGF12B (Figure 3F and
Table 2). This lack of modulation was not due to decreased
expression of either themutant FHF or NaV (Figure S6), so it likely
reflects the absence of interactions with the coexpressed
partner. In contrast, FGF12BK9E induced a depolarizing shift in
steady-state inactivation for Nav1.5E1890K that was similar to
the shift induced by wild-type FGF12B for wild-type NaV1.5.
To test whether the absence of the salt bridge between Nav1.1
and FGF12B accounts for the fact that FGF12B cannot modulate
Nav1.1, we thenmeasured the affinities by ITC between FGF12B
and a wild-type NaV1.1 CTD or a NaV1.1 CTD in which Gln1904
was mutated to Glu (NaV1.1 CTD
Q1904E). As we previously
observed with surface plasmon resonance (Wang et al.,
2011b), the affinity between FGF12B and NaV1.1 CTD is very
low. The affinity between FGF12B and NaV1.1 CTD
Q1904E, was
markedly higher by at least 10-fold, albeit not as high as between
FGF12B wild-type and NaV1.5 CTD (Table 2). Thus, these data
support the hypothesis that binding and function is influenced
by the salt bridge between the FHF Lys and the NaV CTD Glu,
while also pointing to the existence of other determinants not
yet identified.
Interaction between CaM and the Nav1.5 CTD
The interactions between CaM and the NaV CTD are mostly
localized on the C-lobe of CaM and the IQ-motif in a6 (Figure 4A).
The CaM C-lobe adopts a semi-open conformation as observed
in NMR structures of apoCaM bound to an 20 amino acid NaV
IQ motif-containing peptide (Chagot and Chazin, 2011; Feld-
kamp et al., 2011) (rmsd = 1.0 A˚ for the CaM C-lobe with IQ
motif-containing peptide). The CaM C-lobe buries the side
chains of Ile1908 and Gln1909 of the NaV CTD’s IQ motif, and
also contacts the side chains of Ser1904, Ala1905, and
Phe1912 in a6 (Figure 4A). The importance of these observed
interactions is underscored by the epilepsy mutation I1922T in
NaV1.1 (homologous to Ile1908) (Harkin et al., 2007); and
NaV1.5 mutations S1904L (associated with the life-threatening
cardiac arrhythmias Brugada Syndrome [Kapplinger et al.,
2010] and Long QT Syndrome [Bankston et al., 2007]) andhts reserved
Structure
Structure of a NaV CTD in complex with FHF and CaMQ1909R (associated with Long QT Syndrome [Tester et al.,
2005]) (Figure S5).
The linker between the N-lobe and C-lobe of CaM adopts
a helical structure (Figures 1A and 1B). In the NMR structure of
CaM bound to the short IQ motif peptide, the linker is disordered
(Chagot and Chazin, 2011), a discrepancy that is likely because
our crystal structure includes a much bigger portion of the NaV
CTD or because the crystal structure captured one of many
conformational states of the CaM linker in the ternary complex.
The structure of the CaM N-lobe in the ternary complex can be
superimposed on the N-lobe of the crystal structure of apoCaM
with an rmsd of0.8 A˚ (Schumacher et al., 2004) or the N-lobe in
the NMR structure of apoCaM associated with the NaV CTD IQ
motif peptide with an rmsd of1.1 A˚ (Chagot and Chazin, 2011).
Even though we grew our crystals in the presence of 5 mM
EGTA, we observed two electron density peaks in both Ca2+-
binding pockets of the CaM C-lobe. We suspected that the
observed peaks were from Mg2+, not Ca2+, because the crystal-
lization solution contained 100 mM Mg2+. To identify the ions in
the Ca2+-binding pockets, we performed anomalous diffraction
studies on native crystals collected at a long wavelength
(1.54 A˚). At this wavelength, the anomalous scattering power of
Ca2+ (1.1 e) is higher than that of sulfur (0.6 e) and much
higher than that of Mg2+ (0.1 e). If there is an anomalous differ-
ence peak corresponding to an ion in the Ca2+-binding pocket
and it is stronger than those of sulfur in the anomalous difference
Fourier map, the ions must be Ca2+. If there is no significant
anomalous difference peak corresponding to an ion in the
Ca2+-binding pocket or the peak is weaker than those of sulfur,
the ions must be Mg2+. Because we observed many anomalous
difference Fourier peaks from sulfurs in cysteine and methionine
residues, but no notable peaks in theCa2+-binding loops of CaM,
the observed ions in the Ca2+-binding loops of CaM are Mg2+,
not Ca2+. To validate this finding, we isolated a crystal grown
in the absence of Ca2+ and EGTA and soaked it in crystallization
solution containing 5 mM Ca2+ for 45 min before flash-freezing.
We then collected data at a long wavelength (1.6 A˚). The Ca2+-
soaked crystal showed one strong (7.5 s) and one weak
(4 s) anomalous difference peak. The strong peak was much
stronger than those from cysteines and methionines (4 s) (Fig-
ure 5B), suggesting that Ca2+ was successfully incorporated into
the Ca2+-binding loop of CaM. There were no notable structural
changes with Ca2+ binding. Structures of Ca2+-CaM alone show
that the acidic residues (Glu105 and Glu141) on EF hands are
involved in coordination of Ca2+ (Figure 5). In our crystal struc-
ture, the acidic residues are away from the Ca2+-binding loops,
probably because the structure was captured in the apo-CaM
conformation (Figure 5B). However, the Ca2+ binding loop in
the crystal still has a preference for Ca2+ over Mg2+ as a lower
concentration of Ca2+ (5 mM) is enough to replace a high
concentration of Mg2+ (100 mM).
With our crystallographic approach we also queried whether
the NaV CTD’s EF-hand could bind Ca
2+. Ca2+ regulates NaV
channel function but whether it is through Ca2+-CaM or direct
binding of Ca2+ to a putative EF hand in the Nav CTD has been
controversial (Chagot et al., 2009; Kim et al., 2004; Miloushev
et al., 2009; Shah et al., 2006). From the Ca2+-soaked crystal,
we observed no anomalous difference peak in the putative
Ca2+ binding loops of the NaV CTD’s EF-hand (Figure 5C), andStructure 20, 1there was no peak in the putative Ca2+ binding loops of the
Nav CTD’s EF-hand in a 2Fo-Fc map (Figure S7). This observa-
tion is consistent with the idea that any Ca2+-dependent regula-
tion of NaV channels occurs through the bound CaM.
Ternary Interactions among the Nav1.5 CTD, FGF13,
and CaM
Superimposition of the FGF13 structure from the ternary
complex onto the FGF13 structure obtained in the absence of
binding partners (Goetz et al., 2009) shows localized structural
changes around the loop between b8 and b9 (Figure 4B). Upon
binding the NaV CTD and CaM, that loop is reoriented so that
Tyr98 of FGF13 interacts with Arg1898 and Glu1901 of a6 in
NaV1.5 via a cation-p interaction (Gallivan and Dougherty,
1999) and a hydrogen bond interaction, respectively (Figure 4B).
Interestingly, Glu1901 in the NaV1.5 CTD as well as Tyr98 of
FGF13 also are within hydrogen bonding distances with Lys95
of the third Ca2+-binding EF-hand in the CaM C-lobe (Figure 4B).
Mutation of Arg1902 in NaV1.2, homologous to Arg1898 in
NaV1.5, is associated with familial autism (Weiss et al., 2003)
and affects the Ca2+-dependence of the interaction between
the NaV1.2 CTD and CaM (Kim et al., 2004; Weiss et al., 2003).
It is the only site within the ternary complex containing compo-
nents of all three molecules.
DISCUSSION
Our crystal structure, which includes the most structured region
of the CTD as well as two key auxiliary proteins, provides
a cornerstone for understanding the FHF-mediated and/or
CaM-dependent regulation of NaV channels at the molecular
level. In conjunction with the recent structure of a prokaryotic
NaV channel (Payandeh et al., 2011), which does not contain
the CTD, it adds what we believe to be new information that
will help unveil the mechanisms of eukaryotic NaV channel regu-
lation. Most immediately, it provides a basis for exploring the
consequences of certain pathogenic mutations in NaV channels.
For example, the epilepsy-associated mutations D1866Y and
T1909 in NaV1.1 reside in residues that form contacts with the
FHF (see Figures 2 and S5). These mutations might be particu-
larly disrupting for FHF contacts with NaV1.1, because NaV1.1
appears to have a reduced affinity for FHFs compared to
NaV1.5 (see Figure 2 and Wang et al., 2011b). Mutations in
FGF12 or FGF14 prevent targeting of these FHFs and NaV chan-
nels to the axon initial segment (Laezza et al., 2007; Wang et al.,
2011b). Thus, a NaV1.1 epilepsy mutation that disrupts interac-
tions with FHF might lead to a loss-of-function phenotype,
consistent with the proposed model by which NaV1.1 mutations
cause epilepsy (Catterall et al., 2010). Our structure also points to
possible explanations for the epilepsy mutation I1922T (Harkin
et al., 2007), which alters a key residue for interaction with
CaM (Figure 4). Interaction between CaM and NaV channels
has been shown to be critical for channel function; loss of CaM
interactions by mutation in NaV1.4 or NaV1.6 markedly reduced
Na+ channel current density in a heterologous expression
system (Herzog et al., 2003). Growing evidence points to CaM,
constitutively associated with the CTD of the CaV1.2 Ca
2+
channel (Liu et al., 2010; Wahl-Schott et al., 2006), as a regulator
of channel biosynthesis and trafficking in several cell types167–1176, July 3, 2012 ª2012 Elsevier Ltd All rights reserved 1171
Figure 3. Specificity between the NaV1.5 CTD and FGF13
(A) Electrostatic interaction between NaV1.5 CTD (E1890) and FGF13 (K14).
(B) Sequence alignment among NaV isoforms shows that Glu 1890 in NaV1.5 is conserved among other isoforms except NaV1.1.
(C) Sample Isothermal titration calorimetry curves of FGF12B binding to Nav1.5 CTD. The total heat exchanged during each injection is fit to a binding isotherm
with n, KD, andDH
o as independent parameters. KD = 0.123 ± 0.002 mM, n = 1, andDH
o =4,835 ± 235 cal/mol for NaV1.5WT and FGF12BWT. KD = 2.37 ± 0.34 mM,
n = 1.22 and DHo = 1,244 ± 181 cal/mol for NaV1.5WT and FGF12BK9E. KD = 5.04 ± 0.69 mM, n = 0.62, and DHo = 1,001 ± 312 cal/mol for NaV1.5E1890K and
FGF12BWT. KD = 0.088 ± 0.025 mM, n = 0.98, and DH
o = 2,746 ± 202 cal/mol for NaV1.5E1890K and FGF12BK9E. Results are means ± SEM with n = 3.
(D) Coexpression and copurification experiment of wild-type and mutant NaV1.5 CTD and FGF12B shows restoration of interaction with a charge swap.
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Table 2. Contribution of Salt Bridge between FGF12B and NaV1.5
to Binding Affinity and Steady State Inactivation
NaV FGF12B Kd (mM)
V1/2 (Steady State
Inactivation)
NaV1.5
WT — — 90.7 ± 2.0a
NaV1.5
WT WT 0.12 ± 0.002 80.5 ± 1.3
NaV1.5
WT K9E 2.4 ± 0.34a 87.7 ± 1.1a
NaV1.5
E1890K WT 5.0 ± 0.69a 89.8 ± 1.8a
NaV1.5
E1890K K9E 0.09 ± 0.025 82.3 ± 0.7
NaV1.1
WT WT 42.4 ± 12.5 ND
NaV1.1
Q1904E WT 3.7 ± 1.4a ND
ND, not determined.
ap < 0.05 compared to WT-WT. Mean ± SEM with n = 3 for KD and 10–16
for V1/2.
Figure 4. Interactions of NaV CTD with CaM and FGF13
(A) Zoomed-in view of the interactions of the NaV1.5 CTD (green) with the
C-lobe of CaM (magenta) shown on the right. The ternary complex structure on
the left is shown to help orient the figure on the right. The amino acids of the
NaV1.5 CTD involved in interactions with CaM are labeled.
(B) Zoomed-in view of the ternary interactions of the NaV1.5 CTD (green),
FGF13 (yellow), and CaM (magenta). The structure of FGF13 obtained in the
absence of binding partners (PDB ID: 3HBW) was colored brown, showing the
structural change upon formation of the complex.
Structure
Structure of a NaV CTD in complex with FHF and CaM(Poomvanicha et al., 2011; Wang et al., 2007). Indeed, overex-
pression of CaM was shown to rescue a trafficking-defective
epilepsy mutant NaV1.1 channel (Rusconi et al., 2007). By
analogy, therefore, the I1922T mutation may also reduce the
number of NaV1.1 channels at the plasma membrane, thereby
reducing NaV1.1 current. Likewise, the Brugada Syndrome
S1904L mutation in NaV1.5 may also lead to a reduced number
of NaV1.5 channels and/or Na
+ current (Figure S5). This would
be consistent with the loss-of-function consequences of func-
tionally characterized NaV1.5 Brugada Syndrome mutations
(Antzelevitch et al., 2005).
In addition to the insight into effects of mutations, the interface
between the NaV CTD and the FHF offers an unusual model for
protein-protein interactions because critical binding compo-
nents lie at the periphery of the interaction surface. ‘‘Hot-spot’’
residues, those that provide the most binding energy, are usually
found toward the center of the interface (Clackson and Wells,
1995) and are sealed from bulk solvent to provide highly ener-
getic interactions (Bogan and Thorn, 1998). The most notable
interaction in our structure is the salt bridge between a Lys in
the FHF and a Glu in the NaV CTD that contributes greatly to
the interaction energy and offers a means to understand the
reduced interaction between FHFs and NaV1.1 compared to
NaV1.5 (Figure 3 and Wang et al. [2011b]). In a similar manner,
the cation-p interaction between Tyr98 of FGF13 and Arg1898
(Figures 2B and 4B) provides another contact point at the
periphery of the main interface that may have important func-
tional significance for Ca2+-regulation through a hydrogen
bond between Tyr98 of FGF13 and Lys95 of the third Ca2+-
binding EF-hand in the CaM C-lobe (Figure 4B). Mutation of
the homologous residue in the neuronal NaV1.2 (Arg1902) to
cysteine, predicted to disrupt the cation-p interaction, is associ-
atedwith familial autism (Weiss et al., 2003) and affects the Ca2+-
dependence of the interaction between the NaV1.2 CTD and
CaM (Kim et al., 2004;Weiss et al., 2003). Together, these obser-
vations suggest an intriguing possibility that the ternary interac-
tions, including the cation-p interaction between the NaV CTD(E) Exemplar currents from a two-pulse protocol (inset) to assess steady-state in
(F) Both the wild-type pair and the charge swapmutants show a rightward (depola
(values for V1/2 are provided in Table 2). The n for each pair is indicated in paren
See also Figure S6.
Structure 20, 1and FGF13, may serve as a critical mediator between Ca2+/
CaM- and FHF-mediated regulations of NaV currents.
Although a more thorough understanding of how Ca2+ and
CaMparticipate in NaV function will require structural information
with a Ca2+-bound CaM, this Ca2+-free structure provides an
important starting parameter. Most significantly, the anomalous
diffraction studies (Figure 5) support a role for CaM as the Ca2+-
sensor rather than the NaV CTD EF-hand. Further structural and
functional characterization will help test this hypothesis and
unveil the mechanisms of eukaryotic NaV channel regulation.activation of NaV1.5 recorded in HEK293T cells.
rizing) shift. Data are plotted as mean ± SEM and fit with Boltzman distributions
theses.
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Figure 5. Anomalous Diffraction Studies of the CaM C-Lobe and NaV CTD
Anomalous difference Fourier electron density maps of the CaM-C-lobe region from the crystals grown in the presence of EGTA (A) and grown in the absence of
EGTA and soaked with 5 mM Ca2+ (B) are contoured at 3 s and 3.5 s, respectively. Side chains involved in Ca2+ coordination in the Ca2+-binding loops of EF
hands aswell asmethionines are shown. (C) Anomalous difference Fourier electron densitymaps of the NaV1.5 CTD region from the same crystal as (B) contoured
at 3.5 s.
See also Figures S5 and S7.
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Molecular Biology
The following plasmids, for protein expression and purification, have been
previously described: for crystallization the human NaV1.5 CTD (amino acids
1773–1940) was cloned into pET28 (Novagen) (Kim et al., 2004), the human
FGF13U (accession NM_033642) was cloned into the second multiple cloning
site of pETDuet-1 (Novagen) (Wang et al., 2011b), and CaM was cloned into
pSGC02 (Kim et al., 2004). For isothermal titration calorimetry, human
FGF12B (accession NM_004113) and human NaV1.1 CTD (amino acids
1789–1948) were cloned into pET28 (Wang et al., 2011b). For electrophysi-
ology, FGF12B was cloned into pIRES2-acGFP1 (Clontech) as described
(Wang et al., 2011b); and NaV1.5 was cloned into pcDNA3.1 as described
(Wang et al., 2011b). Site-directed mutagenesis of NaV1.1, NaV1.5, or
FGF12B was performed with QuikChange (Stratagene).
Recombinant Protein Expression and Copurification
The three plasmids containing the His6-Nav1.5 CTD, FGF13U, and CaM were
electroporated into BL-21 (DE3) cells. Proteins were expressed after induction
with 1 mM isopropyl-1-thio-b-D-galactopyranoside (IPTG) for 64 hr at 16C.
For expression of selenomethionine incorporated proteins, the cells were
grown in M9 medium with the following additions (mg/L): 100 lysine, phenylal-
anine, and threonine; 50 isoleucine, leucine and valine; and 60 L-selenium-
methionine. Cells were grown until OD600 = 0.7, and then induced with IPTG
as above. Cells were harvested and resuspended in 300 mM NaCl, 20 mM
Tris-HCl, 5 mM imidazole, pH 7.5, supplemented with EDTA-free protease
inhibitor mixture (Roche). Cell extracts were prepared by passage twice
through an Avestin homogenizer (Emulsiflex-C5, Canada) then centrifuged at
146,300 3 g for 25 min. The initial purification protocol has been previously
described (Wang et al., 2008). Additional purification was performed by gel
filtration on a Superdex 200 10/300L column on an AKTA FPLC (GE Health-
care) in 300 mM NaCl, 20 mM Tris-HCl, 5 mM imidazole, with 5 mM EGTA
pH 7.5. Protein concentrations were determined by UV absorbance with
Thermo NANODROP and were concentrated to A280 = 8 in above buffer for
crystallization.
Crystallization, Data Collection, and Structure Determination
Crystals were grown by vapor diffusion with the sitting-drop method. Crystals
were obtained with 20% PEG400, 100 mM magnesium acetate, and 50 mM
sodiumcacodylate, pH 5.3. Before flash-freezing in liquid nitrogen, the crystals
were cryoprotected by gradually increasing the concentration of PEG400 in
the well solution to 38% over a period of 10 min. Single anomalous dispersion
phases were obtained to 2.9 A˚ from SeMet-substituted crystals and then the
phases were extended for model building. The final model was refined to1174 Structure 20, 1167–1176, July 3, 2012 ª2012 Elsevier Ltd All rigRwork/Rfree = 0.210/0.227 and contains NaV1.5 CTD, FGF13, CaM, 3 Mg
2+
(two in the Ca2+ binding sites in CaM and one in the crystallographic contacts),
and 220 waters. The final model is of good Ramachandran statistics (98%
favored and 2% allowed).
The data were collected on beam lines 22ID, 22BM, and 24ID-C at the
Advanced Photon Source. The data were processed using HKL2000 (Otwi-
nowski and Minor, 1997). The data for the SeMet-substituted crystal were
collected at the Se peak wavelength (0.97936 A˚) and the crystal diffracted to
2.9 A˚. Phases were obtained by the single anomalous dispersion technique
using PHASER (McCoy et al., 2007) from the PHENIX interface (Adams
et al., 2010) with a figure of merit of 0.42. Phases were extended to 2.4 A˚ by
solvent flattening using RESOLVE (Terwilliger, 2000) against high-resolution
native data (2.2 A˚). Approximately 60% of the entire model was built using
AutoBuild from the PHENIX interface. Further model building was done manu-
ally using COOT (Emsley and Cowtan, 2004). Structure refinement was done
using the high-resolution (2.2 A˚) native data.
For anomalous diffraction studies, the data for the native crystal grown in the
presence of EGTA were collected to 2.6 A˚ Bragg spacings using the rotating
anode generator (Rigaku MicroMax-007 HF micro focus) at the Duke Univer-
sity X-ray Crystallography facility and the data for the Ca2+-soaked crystals
to 2.45 A˚ Bragg spacings were collected at a wavelength of 1.6 A˚ using the
beam line 24ID-C at the Advanced Photon Source. At least 180 images were
collected for all the data sets. Anomalous difference Fourier maps were calcu-
lated using the phases from the structure of the ternary complex using
PHENIX.
Isothermal Titration Calorimetry
Experiments were performed with an ITC-200 (MicroCal) at 20C. Solution
containing NaV1.5, NaV1.1, NaV1.5
E1890K, or NaV1.1
Q1904K CTD (20–51 mM)
were titrated with 20–30 10-ml injections of solution containing FGF12B or
FGF12BK9E (240–510 mM). ITC experiments were repeated with different prep-
arations and different concentrations at least three times to confirm thermody-
namic parameters and stoichiometry values. The binding isotherms were
analyzed with a single site binding model using the Microcal Origin version
7.0 software package (Originlab Corporation), yielding binding enthalpy (DH),
stoichiometry (n), entropy (DS), and association constant (Ka). Due to the low
affinity between the single mutation and wild-type interaction, higher concen-
trations of FGF12B were used. Results are presented as mean ± SEM; statis-
tical significance was assessed using a two-tailed Student’s t test and was set
at p < 0.05.
Electrophysiology
HEK293T cells were transfected at 60% confluence using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. The total amount ofhts reserved
Structure
Structure of a NaV CTD in complex with FHF and CaMDNA for all transfections was kept constant. Transfected cells were identified
by GFP fluorescence. Na+ currents were recorded using the whole-cell patch-
clamp technique at room temperature (20–22C) 48–72 hr after transfection.
Electrode resistance ranged from 2–4 MU. Currents were filtered at 5 kHz
and digitized using an analog-to-digital interface (Digidata 1322A, Axon Instru-
ments). Capacitance and series resistance were adjusted (70% to 85%) to
obtain minimal contribution of the capacitive transients. The bath solution con-
tained (in mM): NaCl 130, KCl 4, CaCl2 1.8, MgCl2 1, HEPES 10, glucose 10,
pH 7.35 (adjusted with NaOH). The intracellular solution contained (in mM):
CsF 110, EGTA 10, NaF 10, CsCl 20, HEPES 10, pH 7.35 (adjusted with
CsOH). Osmolarity was adjusted to 310 mOsm with sucrose for all solutions.
Standard two-pulse protocols were used to generate the steady-state inacti-
vation curves: from a holding potential of 120 mV, cells were stepped to
500-ms preconditioning potentials varying between 130 mV and 10 mV
(prepulse), followed by a 20ms test pulse to20mV. Currents (I) were normal-
ized to Imax and fit to a Boltzmann function of the form I/Imax = 1/{1 + exp[(Vm
V1/2)/k]} in which V1/2 is the voltage at which half of NaV1.5 channels are inac-
tivated, k is the slope factor, and Vm is the membrane potential. Data analysis
was performed using Clampfit 10.2 software (Axon Instruments) and Origin 8.
Results are presented as means ± SEM; the statistical significance of differ-
ences between groups was assessed using a two-tailed Student’s t test and
was set at p < 0.05.ACCESSION NUMBERS
Atomic coordinates and structure factors for the reported crystal structure
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